SC
BIO icon

Sierra Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sierra Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29
Closed -$12K – 229
2022
Q4 		$12K Hold
29
– – ﹤0.01% 339
2022
Q3 		$12K Hold
29
– – ﹤0.01% 353
2022
Q2 		$14K Hold
29
– – ﹤0.01% 419
2022
Q1 		$16K Hold
29
– – ﹤0.01% 427
2021
Q4 		$22K Hold
29
– – ﹤0.01% 401
2021
Q3 		$22K Sell
29
-7
-19% -$5.24K ﹤0.01% 342
2021
Q2 		$23K Hold
36
– – ﹤0.01% 324
2021
Q1 		$21K Buy
+36
New +$21.3K ﹤0.01% 310

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return